Dexter L Cooper1, Natalie D Hernandez2, Latrice Rollins2, Tabia Henry Akintobi2, Calvin McAllister2. 1. Morehouse School of Medicine, Department of Community Health and Prevention Medicine, Prevention Research Center, United States. Electronic address: dcooper@msm.edu. 2. Morehouse School of Medicine, Department of Community Health and Prevention Medicine, Prevention Research Center, United States.
Abstract
INTRODUCTION: Black and Hispanic men are diagnosed with more HPV-related cancers and at later stages compared to other racial/ethnic groups. Physician communication with men about HPV vaccination may be beneficial to increasing HPV vaccinations and decreasing HPV transmission. The purpose of this study was to examine HPV and HPV vaccine awareness among men by race, and the association between trust in cancer information from physicians and ever hearing about HPV and the HPV vaccine. METHODS: U.S. adult males (age 18+) were identified from the 2014 Health Information National Trends Survey (HINTS) (n=1203). Binomial logistic regression models assessed the influences of race/ethnicity and trust of cancer information from physicians on men having heard of HPV and the HPV vaccination. RESULTS: Approximately 50% of the sample had never heard of HPV and 53% had never heard of the vaccine. Black men were less likely to know that HPV is sexually transmitted compared to White and Hispanic men (p<0.001). Hispanic and Black men were less likely to have heard about the HPV vaccine when compared to White men (p<0.001). Additionally, Hispanic men were less likely to trust a doctor about cancer information compared to White and Black men (p<0.001). CONCLUSION: Findings highlight the lack of awareness about HPV among men. Furthermore, statistically significant racial/ethnic differences were found in HPV vaccine knowledge and trust in receiving cancer information from physicians. Future interventions should include community-based approaches and improved physicians' HPV-related communication to increase knowledge and uptake of the HPV vaccine.
INTRODUCTION: Black and Hispanic men are diagnosed with more HPV-related cancers and at later stages compared to other racial/ethnic groups. Physician communication with men about HPV vaccination may be beneficial to increasing HPV vaccinations and decreasing HPV transmission. The purpose of this study was to examine HPV and HPV vaccine awareness among men by race, and the association between trust in cancer information from physicians and ever hearing about HPV and the HPV vaccine. METHODS: U.S. adult males (age 18+) were identified from the 2014 Health Information National Trends Survey (HINTS) (n=1203). Binomial logistic regression models assessed the influences of race/ethnicity and trust of cancer information from physicians on men having heard of HPV and the HPV vaccination. RESULTS: Approximately 50% of the sample had never heard of HPV and 53% had never heard of the vaccine. Black men were less likely to know that HPV is sexually transmitted compared to White and Hispanic men (p<0.001). Hispanic and Black men were less likely to have heard about the HPV vaccine when compared to White men (p<0.001). Additionally, Hispanic men were less likely to trust a doctor about cancer information compared to White and Black men (p<0.001). CONCLUSION: Findings highlight the lack of awareness about HPV among men. Furthermore, statistically significant racial/ethnic differences were found in HPV vaccine knowledge and trust in receiving cancer information from physicians. Future interventions should include community-based approaches and improved physicians' HPV-related communication to increase knowledge and uptake of the HPV vaccine.
Authors: Kristina R Dahlstrom; Ann N Burchell; Agnihotram V Ramanakumar; Allita Rodrigues; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-12 Impact factor: 4.254
Authors: Ellen M Daley; Stephanie Marhefka; Eric Buhi; Natalie D Hernandez; Rasheeta Chandler; Cheryl Vamos; Stephanie Kolar; Christopher Wheldon; Mary R Papenfuss; Anna R Giuliano Journal: Vaccine Date: 2011-04-01 Impact factor: 3.641
Authors: Kelly D Blake; Allison J Ottenbacher; Lila J Finney Rutten; Meredith A Grady; Sarah C Kobrin; Robert M Jacobson; Bradford W Hesse Journal: Am J Prev Med Date: 2015-02-18 Impact factor: 5.043
Authors: Chanita Hughes Halbert; Benita Weathers; Ernestine Delmoor; Brandon Mahler; James Coyne; Hayley S Thompson; Thomas Ten Have; David Vaughn; S Bruce Malkowicz; David Lee Journal: Cancer Date: 2009-06-01 Impact factor: 6.860
Authors: Mary K Grabowski; Xiangrong Kong; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Andrew D Redd; Stephen Watya; Thomas C Quinn; Aaron A R Tobian Journal: J Infect Dis Date: 2015-11-23 Impact factor: 5.226
Authors: William R Carpenter; Paul A Godley; Jack A Clark; James A Talcott; Timothy Finnegan; Merle Mishel; Jeannette Bensen; Walter Rayford; L Joseph Su; Elizabeth T H Fontham; James L Mohler Journal: Cancer Date: 2009-11-01 Impact factor: 6.860
Authors: Heather M Brandt; Robin C Vanderpool; Susan J Curry; Paige Farris; Jason Daniel-Ulloa; Laura Seegmiller; Lindsay R Stradtman; Thuy Vu; Victoria Taylor; Maria Zubizarreta Journal: Hum Vaccin Immunother Date: 2019-06-03 Impact factor: 3.452
Authors: Matthew Z Dudley; Rupali J Limaye; Daniel A Salmon; Saad B Omer; Sean T O'Leary; Mallory K Ellingson; Christine I Spina; Sarah E Brewer; Robert A Bednarczyk; Fauzia Malik; Paula M Frew; Allison T Chamberlain Journal: Public Health Rep Date: 2021-01-28 Impact factor: 2.792
Authors: Yuki Lama; Tao Chen; Mark Dredze; Amelia Jamison; Sandra Crouse Quinn; David A Broniatowski Journal: J Med Internet Res Date: 2018-09-14 Impact factor: 5.428
Authors: Almudena Recio-Román; Manuel Recio-Menéndez; María Victoria Román-González Journal: Int J Environ Res Public Health Date: 2022-03-10 Impact factor: 3.390